Search results
The FDA Should Reject MDMA Therapy—but Not for the Reasons You Think
Slate via Yahoo News· 13 hours agoBut mistakes in the FDA’s approval history should illustrate the dangers of rubber-stamping drugs...
Abortion pills survive Supreme Court challenge but face other restrictions across U.S.
Gannett via AOL· 11 hours agoThose safety concerns do not apply to modern abortion medications, Thompson said. "We're now talking...
Experimental Alzheimer’s drug gets FDA advisory panel's thumbs-up: ‘Progress is happening’
Fox News· 2 days agoAn experimental Alzheimer’s drug, donanemab, was endorsed by a U.S. Food and Drug Administration (...
FDA panel rejects MDMA-assisted therapies for PTSD despite high hopes from veterans
Fox News· 19 hours agoA U.S. Food and Drug Administration (FDA) panel rejected MDMA-based treatments for post-traumatic...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 7 days agoMLB Announces IND Approval by US FDA to Initiate Phase 1 Trial of TML-6, a New Era Multi-Target Drug for the Treatment of Alzheimer's ...
Eli Lilly’s Alzheimer’s drug to face safety, dosing scrutiny from FDA advisers
Market Watch· 7 days agoIn a briefing document prepared for the advisory committee, the FDA raised questions about a unique...
Eli Lilly's Alzheimer's Drug Gains Unanimous FDA Panel Backing
Verywell Health via Yahoo News· 2 days agoAn FDA advisory panel endorsed donanemab, Eli Lilly’s monoclonal antibody drug designed to slow the...
Geron stock steady as analysts maintain 'buy' rating with $10 target By Investing.com
Investing.com· 6 days agoThe approval by the Food and Drug Administration (FDA) was granted one week before the anticipated...
FDA grants Shattuck Labs orphan drug status for AML treatment By Investing.com
Investing.com· 3 days ago(FDA) has awarded orphan drug designation to its lead clinical candidate, SL-172154, aimed at...
FDA's Unanimous Approval of Donanemab: A Glimmer of Hope in Alzheimer's Treatment - Tribune-Review
Pittsburgh Tribune-Review· 2 days agoIn the ongoing battle against Alzheimer's disease, a glimmer of hope emerged yesterday with the Food & Drug Administration’s (FDA) unanimous approval ...